These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
65 related articles for article (PubMed ID: 9597811)
1. Suppression of HIV-1 replication in peripheral blood mononuclear cells by fasudil. Akari H; Yamamoto Y; Hiwada H; Saito Y; Takayanagi N; Koyama AH; Adachi A J Med Invest; 1998 Feb; 44(3-4):211-4. PubMed ID: 9597811 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of human immunodeficiency virus type 1 replication by a bioavailable serine/threonine kinase inhibitor, fasudil hydrochloride. Sato T; Asamitsu K; Yang JP; Takahashi N; Tetsuka T; Yoneyama A; Kanagawa A; Okamoto T AIDS Res Hum Retroviruses; 1998 Mar; 14(4):293-8. PubMed ID: 9519889 [TBL] [Abstract][Full Text] [Related]
3. Effect of Fasudil HCl, a protein kinase inhibitor, on cerebral vasospasm. Shibuya M; Asano T; Sasaki Y Acta Neurochir Suppl; 2001; 77():201-4. PubMed ID: 11563286 [No Abstract] [Full Text] [Related]
4. Inhibition of HIV-1 Nef-induced apoptosis of uninfected human blood cells by serine/threonine protein kinase inhibitors, fasudil hydrochloride and M3. Okada H; Takei R; Tashiro M FEBS Lett; 1998 Feb; 422(3):363-7. PubMed ID: 9498817 [TBL] [Abstract][Full Text] [Related]
5. Highly potent inhibition of human immunodeficiency virus type 1 replication by TAK-220, an orally bioavailable small-molecule CCR5 antagonist. Takashima K; Miyake H; Kanzaki N; Tagawa Y; Wang X; Sugihara Y; Iizawa Y; Baba M Antimicrob Agents Chemother; 2005 Aug; 49(8):3474-82. PubMed ID: 16048963 [TBL] [Abstract][Full Text] [Related]
7. Neutrophils from human immunodeficiency virus (HIV)-seronegative donors induce HIV replication from HIV-infected patients' mononuclear cells and cell lines: an in vitro model of HIV transmission facilitated by Chlamydia trachomatis. Ho JL; He S; Hu A; Geng J; Basile FG; Almeida MG; Saito AY; Laurence J; Johnson WD J Exp Med; 1995 Apr; 181(4):1493-505. PubMed ID: 7699332 [TBL] [Abstract][Full Text] [Related]
8. Persistence of HIV-1 transcription in peripheral-blood mononuclear cells in patients receiving potent antiretroviral therapy. Furtado MR; Callaway DS; Phair JP; Kunstman KJ; Stanton JL; Macken CA; Perelson AS; Wolinsky SM N Engl J Med; 1999 May; 340(21):1614-22. PubMed ID: 10341273 [TBL] [Abstract][Full Text] [Related]
9. The kinase inhibitor fasudil (HA-1077) reduces intimal hyperplasia through inhibiting migration and enhancing cell loss of vascular smooth muscle cells. Negoro N; Hoshiga M; Seto M; Kohbayashi E; Ii M; Fukui R; Shibata N; Nakakoji T; Nishiguchi F; Sasaki Y; Ishihara T; Ohsawa N Biochem Biophys Res Commun; 1999 Aug; 262(1):211-5. PubMed ID: 10448094 [TBL] [Abstract][Full Text] [Related]
10. Safety and efficacy of fasudil monotherapy and fasudil-ozagrel combination therapy in patients with subarachnoid hemorrhage: sub-analysis of the post-marketing surveillance study. Suzuki Y; Shibuya M; Satoh S; Sugiyama H; Seto M; Takakura K Neurol Med Chir (Tokyo); 2008 Jun; 48(6):241-7; discussion 247-8. PubMed ID: 18574328 [TBL] [Abstract][Full Text] [Related]
11. Immortalized Epstein-Barr virus-positive B-cell lines obtained by prolonged culture of peripheral blood mononuclear cells from human immunodeficiency virus type 1-positive patients. Ruibal-Ares B; Belmonte L; Baré P; Scolnik M; Palacios MF; Bayo-Hanza C; Galmarini CM; Mendez G; de Bracco MM J Hum Virol; 2001; 4(4):200-13. PubMed ID: 11694848 [TBL] [Abstract][Full Text] [Related]
13. Viral dynamics in human immunodeficiency virus type 1 infection. Wei X; Ghosh SK; Taylor ME; Johnson VA; Emini EA; Deutsch P; Lifson JD; Bonhoeffer S; Nowak MA; Hahn BH Nature; 1995 Jan; 373(6510):117-22. PubMed ID: 7529365 [TBL] [Abstract][Full Text] [Related]
14. Thromboxane A2 synthetase inhibitor failed to ameliorate the arterial narrowing during the chronic phase of cerebral vasospasm. Toshima Y; Satoh S; Ikegaki I; Asano T; Suzuki Y; Shibuya M Life Sci; 1997; 61(14):1371-7. PubMed ID: 9335226 [TBL] [Abstract][Full Text] [Related]
15. Divergent regulation of HIV-1 replication in PBMC of infected individuals by CC chemokines: suppression by RANTES, MIP-1alpha, and MCP-3, and enhancement by MCP-1. Vicenzi E; Alfano M; Ghezzi S; Gatti A; Veglia F; Lazzarin A; Sozzani S; Mantovani A; Poli G J Leukoc Biol; 2000 Sep; 68(3):405-12. PubMed ID: 10985258 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of neutrophil migration by a protein kinase inhibitor for the treatment of ischemic brain infarction. Satoh S; Kobayashi T; Hitomi A; Ikegaki I; Suzuki Y; Shibuya M; Yoshida J; Asano T Jpn J Pharmacol; 1999 May; 80(1):41-8. PubMed ID: 10446755 [TBL] [Abstract][Full Text] [Related]
17. Replication of HIV-1 in human peripheral blood mononuclear cells activated by exogenous Nef. Torres BA; Tanabe T; Johnson HM AIDS; 1996 Aug; 10(9):1042-3. PubMed ID: 8853740 [No Abstract] [Full Text] [Related]
18. Isolation and propagation of HIV-1 on peripheral blood mononuclear cells. van 't Wout AB; Schuitemaker H; Kootstra NA Nat Protoc; 2008; 3(3):363-70. PubMed ID: 18323807 [TBL] [Abstract][Full Text] [Related]
19. Interleukin-16 does not suppress HIV-1 replication in naturally infected peripheral blood mononuclear cells. Gao M; Tsuchie H; Detorio MA; Hossain MM; Owatari S; Zhang J; Taniguchi K; Nishimoto A; Shirono H; Koga J; Takata N; Matsumoto T; Yoshizaki K; Kurimura T AIDS; 1997 Mar; 11(4):538-9. PubMed ID: 9084805 [No Abstract] [Full Text] [Related]